Guillermo Umpierrez, MD
Enriched profileProfessor of Medicine, Division of Endocrinology, Metabolism and Lipids · Emory University School of Medicine
Guillermo Umpierrez is Professor of Medicine, Division of Endocrinology, Metabolism and Lipids at Emory University School of Medicine. OpenAlex indexes 823 publications with 48,528 citations (h-index 109); ClinicalTrials.gov lists 46 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Guillermo Umpierrez, MD, is Professor of Medicine, Division of Endocrinology, Metabolism and Lipids at Emory University School of Medicine, Division of Endocrinology, Metabolism and Lipids. The public record shows 823 publications with 48,528 citations (h-index 109), centered on Diabetes Management and Research, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Diabetes Treatment and Management. It also documents an investigator role on 46 registered clinical trials, industry payments reported by 11 companies, 3 NIH-funded awards (2005–2025).
- Most recent indexed publication: 2026 · Diabetes care
- Top research focus: Diabetes Management and Research
- 46 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 104 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 394.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 46 registered studies on ClinicalTrials.gov. The most recent:
- FreeStyle Libre 2 Discharge Trial
Sponsor: Palo Alto Medical Foundation
- Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes
Sponsor: Emory University
Industry payments
Updated 14 Oct 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- SANOFI PASTEUR INC.Program year20251 payment$14,214openpaymentsdata.cms.gov ↗
- SANOFI-AVENTIS U.S. LLCProgram year20252 payments
- RECORDATI_RARE_DISEASES_INC.Program year20256 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
84.7%SGLT2 inhibitor27.8%Farxiga100%Part D≥12 patientsGLP-1 receptor agonist25%Ozempic100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
15.3%Calcium channel blocker15.3%Amlodipine Besylate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
3 NIH research awards on record, funded 2005–2025 per NIH RePORTER. The latest:
Congress activity
Updated 14 Oct 2026
109 congress contributions (2017–2025) across AACE, ADA, ENDO per OpenAlex. The most recent:
- 1011-P: Refined Time-in-Range Analysis for Continuous Glucose Monitoring—Mitigating Bias from Missing Data in Inpatient Glycemic Control
ADA Scientific Sessions
ADA2025Co-authorPoster - 1533-P: A1C at Insulin Discontinuation Is Associated with Higher Insulin Secretion in Ketosis Prone Diabetes (KPD)
ADA Scientific Sessions
ADA2025Co-authorPoster - 160-OR: Assessing the Real-World Effectiveness of the VA MOVE! Lifestyle Program in Preventing Type 2 Diabetes—A 15-Year Follow-up Study
ADA Scientific Sessions
ADA2025Co-authorOral
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation.
BMJ open diabetes research & care
Article2026 - Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target Trial.
Journal of the American Heart Association
Article2026 - Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report.
Journal of diabetes science and technology
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Hyperglycemic Crises in Adult Patients With Diabetes2,060 citations2009
- 03
- 04
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/guillermo-umpierrez-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/guillermo-umpierrez-827008212
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/lab/Guillermo-E-Umpierrez-Lab
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - ResearchGate
researchgate.net/scientific-contributions/Guillermo-Umpierrez-2147912397
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/guillermo-umpierrez-881974341
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
music.amazon.com/podcasts/4ba94732-0521-4956-bfea-086f787d22df/diabetes-technology-report
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →music.amazon.com ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/diabetes-core-update/id501572453
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - X / Twitter
x.com/TheEndoSociety/status/1336294603734061057
- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Residency
Internal Medicine, Emory University School of Medicine (1982-1985); Fellowship, Endocrinology, Diabetes and Metabolism, Emory University School of Medicine
1987provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ssciweb.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ssciweb.org ↗
- Board certified in Internal Medicine and Endocrinology
Diabetes & Metabolism
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →globenewswire.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globenewswire.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globenewswire.com ↗
- Director of Clinical Research
Emory Center of Diabetes and Metabolism
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.emory.edu ↗ - Director
Grady Memorial Hospital Clinical Research Network / Director of Diabetes and Endocrinology Section, Grady Memorial Hospital (Atlanta)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.emory.edu ↗ - Editor-in-Chief
BMJ Open Diabetes Research & Care; Editor-in-Chief, ADA's Therapy for Diabetes Mellitus and Related Disorders ("Green Book")
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diabetesjournals.org ↗ - Director
Emory Latino Diabetes Education Program
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →globenewswire.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinenews.endocrine.org ↗
- National awards from American College of Physicians
American Association of Clinical Endocrinologists (AACE), and American Diabetes Association (ADA) …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.emory.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnologyreport.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →glytec.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.emory.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Guy McKhann, MD
Emory University School of Medicine
Arshed Quyyumi, MD
Emory University School of Medicine
Stewart Factor, DO
Emory University School of Medicine
Nadine Rouphael, MD
Emory University School of Medicine
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine